PA
HGV icon

PharVision Advisers’s Hilton Grand Vacations HGV Stock Holding History

PharVision Advisers’s Portfolio HGV Stock Details HGV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,020
Closed -$252K – 823
2025
Q3 		$252K Buy
+6,020
New +$277K 0.14% 326

Other funds holding HGV

AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HPC
Hill Path Capital New York $1.37B AUM 15.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return

PharVision Advisers's HGV Position: Q4 2025 in Review

PharVision Advisers sold out of Hilton Grand Vacations (HGV) in Q4 2025, closing a stake of 6,020 shares — an estimated $252K sold.

PharVision Advisers first reported a position in HGV in Q3 2025 and held it in 1 quarter. The position peaked at $252K in Q3 2025. 267 funds tracked by Wall St. Rank hold HGV as of Q4 2025.

  • PharVision Advisers reported no remaining Hilton Grand Vacations position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 6,020 Hilton Grand Vacations shares in Q4 2025, an estimated $252K.
  • PharVision Advisers first reported a position in Hilton Grand Vacations in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's Hilton Grand Vacations position peaked at $252K in Q3 2025.
  • 267 funds tracked by Wall St. Rank held Hilton Grand Vacations as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.